Showing results (2451-2460 of 2,940) with videos related to
Sort By:
Pageof 294
Cancer Investigation|December 9, 2009
Activation of corticotropin-releasing factor receptor 2 inhibits the growth of human small cell lung carcinoma cellsJuejin Wang, Lai Jin, Jie Chen, et al.Cancer Investigation|January 16, 2010
Epidermal growth factor induces cell death in the absence of overexpressed epidermal growth factor receptor and ErbB2 in various human cancer cell linesJene Choi, Soo Young Moon, Joon Pio Hong, et al.Cancer Investigation|January 16, 2010
Treatment interruption and discontinuation in radiotherapy for rectal cancerBenjamin Lebwohl, Leslie Ballas, Yin Cao, et al.Cancer Investigation|January 16, 2010
The role of NF-kappaB in Hepatitis b virus X protein-mediated upregulation of VEGF and MMPsLi-ping Liu, Hui-fang Liang, Xiao-ping Chen, et al.Cancer Investigation|May 3, 2017
Simvastatin and MBCD Inhibit Breast Cancer-Induced Osteoclast Activity by Targeting Osteoclastogenic FactorsKaushik Chowdhury, Ankit Sharma, Tanu Sharma, et al.Cancer Investigation|July 11, 2017
Long Term Low Molecular Weight Heparin Anticoagulant Therapy Modulates Thrombin Generation and D-dimer in Patients with Cancer and Venous ThromboembolismAndrea D'Alessio, Marina Marchetti, Carmen Julia Tartari, et al.Cancer Investigation|July 11, 2017
Using Delayed Toxicities to Re-evaluate Tolerability in Phase 2 Trials: A Case Example using BortezomibShing M Lee, Yuan Zhang, Lori M Minasian, et al.Cancer Investigation|January 1, 1992
Chemical radiosensitizers in cancer therapyM A Shenoy, B B SinghCancer Investigation|January 1, 1992
Tamoxifen in axillary node--negative breast cancer: multisystem benefits and risksR R LoveCancer Investigation|February 4, 2010
Curcumin inhibits constitutive STAT3 phosphorylation in human pancreatic cancer cell lines and downregulation of survivin/BIRC5 gene expressionW Glienke, L Maute, J Wicht, et al.Pageof 294